Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that the company’s CyberKnife® VSI™ System received the 2010 Minnie for Best New Radiology Device from AuntMinnie.com, the largest and most comprehensive community internet site for radiologists and related professionals in the medical imaging industry.
Accuray will be presented with the award at the 2010 Radiological Society of North America (RSNA) annual meeting taking place in Chicago, Ill. from November 28 – December 3, 2010.
“The Minnies awards have been an important barometer of excellence in radiology for the past 11 years,” said Brian Casey, editor in chief of AuntMinnie.com. “We’re pleased to recognize Accuray’s CyberKnife VSI System as the Best New Radiology Device of the year.”
Through Accuray’s R&D commitment to clinically-driven product enhancements that meet the needs of its customers and improve patient care, the company announced the CyberKnife VSI System in November 2009.
The CyberKnife VSI System leverages the versatility, simplicity, and intelligence of the CyberKnife System to broaden the range of treatment options physicians can offer their patients – from radiosurgery to conventionally fractionated Robotic IMRT™.
By supporting this full spectrum of fractionation schemes, the CyberKnife VSI System allows for more customized treatment plans based on patient-specific situations and conditions, such as patients requiring re-irradiation of previously treated areas, or patients requiring partial breast irradiation.
Cutting-edge product enhancements, including a world-class 1,000 MU/minute X-band linear accelerator and auto-segmentation capabilities, make planning and delivery simple, convenient and fast for routine clinical use.
“We are honored to receive this designation from such an influential industry publication,” said Euan S. Thomson, Ph.D., president and CEO of Accuray. “The team at Accuray is incredibly proud of the CyberKnife VSI System and the benefits it brings to helping patients win their fight against cancer.”
Source : Accuray Incorporated